Özge’s background is in research; she holds a MSc. in Molecular Genetics from the University of Leicester and a PhD. in Developmental Biology from the University of London. Özge worked as a bench ...

Patients with Wilson disease are at risk of osteoporosis and osteopenia, particularly older, male patients and those with skeletal symptoms.

Nipocalimab is a fully human, IgG1, high-affinity monoclonal antibody that blocks placental IgG transfer and reduces levels of circulating maternal IgG.

Routine immunoglobulin G (IgG) monitoring may help identify pediatric patients with acute lymphoblastic leukemia (ALL) at risk for hypogammaglobulinemia and frequent febrile episodes during ...

Careful attention to blood sample handling, including maintaining a warm chain, can help identify cold agglutinin disease (CAD).

Serum transthyretin levels appear to correlate with worse prognosis in patients with transthyretin amyloid cardiomyopathy (ATTR-CM), a study found.

The suspicion of cardiac amyloidosis is still age-biased among healthcare professionals. In spite of recent educational efforts.

The US Food and Drug Administration (FDA) notified Sarepta Therapeutics that it may now lift the ban on the shipment of its Duchenne muscular dystrophy (DMD) drug, delandistrogene moxeparvovec ...

A multimodal approach combining vosoritide and limb lengthening led to gains in stature, gait, and emotional well-being in achondroplasia.

The presence of intracutaneous amyloid deposition in asymptomatic TTR mutation carriers could be a predictive of ATTR-CM progression.

A new set of consensus-based statements (CSs) on appropriate myelofibrosis (MF) management for the Asia-Pacific (APAC) region.

Results of the ApproaCH trial showed that navepegritide improved AGV over placebo in pediatric patients with achondroplasia.